References
-
1
Hirota W K, Loughney T M, Lazas D J. et al .
Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.
Gastroenterology.
1999;
116
277-285
-
2
Spechler S J, Goyal R K.
Barrett’s esophagus.
N Engl J Med.
1986;
315
362-371
-
3
DeVault K R.
Epidemiology and significance of Barrett’s esophagus.
Dig Dis.
2000;
18
195-202
-
4
Clark G WB, Smyrk T C, Burdeles P. et al .
Is Barrett’s metaplasia the source of adenocarcinoma of the cardia?.
Arch Surg.
1994;
129
609-614
-
5
Cameron A J, Lomboy C T, Pera M. et al .
Adenocarcinoma of the esophagogastric junction and Barrett’s esophagus.
Gastroenterology.
1995;
109
1541-1546
-
6
Oberg S, Clark G WB, DeMeester T R.
Barrett’s esophagus: update of pathophysiology and management.
Hepatogastroenterology.
1998;
45
1348-1356
-
7
Nandurkar S, Talley N J.
Barrett’s esophagus: The long and the short of it.
Am J Gastroenterol.
1999;
94
30-40
-
8
Spechler S J, Zeroogian J M, Antonioli D A. et al .
Prevalence of metaplasia at the gastroesophageal junction.
Lancet.
1994;
344
1533-1536
-
9
Kountouras J, Boura P, Lygidakis N J.
New concepts of molecular biology for colon carcinogenesis.
Hepatogastroenterology.
2000;
47
1291-1297
-
10
Ida K, Hashimoto Y, Kawai K.
In vivo staining of gastric mucosa: its application to endoscopic diagnosis of intestinal metaplasia.
Endoscopy.
1975;
7
18-24
-
11
Fennerty M B, Sampliner R E, McGee D L. et al .
Intestinal metaplasia in the stomach: identification by a selective mucosal staining technique.
Gastrointest Endosc.
1992;
38
696-698
-
12
Canto M I.
Vital staining and Barrett’s esophagus.
Gastrointest Endosc.
1999;
49
S12-S16
-
13
Canto M I, Setrakian S, Willis J. et al .
Methylene blue-directed biopsy for improved detection of intestinal metaplasia and dysplasia in Barrett’s esophagus: a controlled sequential trial [abstract].
Gastrointest Endosc.
1996;
43
165
-
14
Sampliner R E.
Practice Parameters Committee of the American College of Gastroenterology. Practice guidelines on the diagnosis, surveillance and therapy of Barrett’s esophagus.
Am J Gastroenterol.
1998;
93
1028-1032
-
15
Gruppo Operativo per lo Studio delle Precancerosi dell’Esofago (GOSPE).
Barrett’s esophagus: epidemiological and clinical results of a multicentric survey.
Int J Cancer.
1991;
48
364-368
-
16
Kim S, Waring P, Spechler S. et al .
Diagnostic inconsistencies in Barrett’s esophagus.
Gastroenterology.
1994;
107
945-949
-
17
Woolf G, Riddell R, Irvine E, Hunt R.
A study to examine agreement between endoscopy and histology for the diagnosis of columnar-lined (Barrett’s) esophagus.
Gastrointest Endosc.
1989;
35
541-544
-
18
Stevens P, Lightdale C, Green P. et al .
Combined magnification endoscopy with chromoendoscopy for the evaluation of Barrett’s esophagus.
Gastrointest Endosc.
1994;
40
747-749
-
19
Canto M IF, Setrakian S, Petras R E. et al .
Methylene blue selectively stains intestinal metaplasia in Barrett’s esophagus.
Gastrointest Endosc.
1996;
44
1-7
-
20
Morales T G, Bhattacharyya A, Camargo E. et al .
Methylene blue staining for intestinal metaplasia of the gastric cardia with follow-up for dysplasia.
Gastrointest Endosc.
1998;
48
26-31
-
21
Kiesslich R, Hahn M, Hermann G, Jung M.
Screening for specialized columnar epithelium with methylene blue: chromoendoscopy in patients with Barrett’s esophagus and a normal control group.
Gastrointest Endosc.
2001;
53
47-52
-
22
Sharma P, Topalovski M, Mayo M S, Weston A P.
Methylene blue chromoendoscopy for detection of short-segment Barrett’s esophagus.
Gastrointest Endosc.
2001;
54
289-293
G. Kouklakis, M.D.
51 Androutsou St. · 55132 N. Krini · Thessaloniki · Greece
Fax: + 30-310-241941
eMail: gastro@hol.gr
